Market introduction of psychedelics as a therapy looks promising. However, policy and regulatory issues concerning the drug class still exist.
New research provides insight into the debate centered around the brain's capacity to synthesize DMT endogenously.
A look into the potential therapeutic application of psychedelics in disorders of consciousness.
Oakland activists arrange May 28 meeting with the city council to discuss decriminalizing entheogens.
A look into the cognitive-enhancing effects of psychedelics in sports.
Scientific and public opinion is slowly shifting for the potential usage of psilocybin in a variety of conditions. Can the same be said for recreational usage?
FDA approval for psilocybin-assisted therapy for depression appears to be on the horizon.